Anebulo Pharmaceuticals宣布首批患者在静脉注射塞洛那班特的1期单次递增剂量研究中接受给药,该药物正在开发用于治疗急性大麻诱发毒性

美股速递
Sep 25, 2025

Anebulo Pharmaceuticals宣布首批患者在静脉注射塞洛那班特的1期单次递增剂量研究中接受给药,该药物正在开发用于治疗急性大麻诱发毒性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10